Logo
Secure Registration

International Conference on Rheumatology and Biologic Therapies

ICRBT

13th Jan – 14th Jan 2027 Incheon, South Korea

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

1

Select Registration Mode

2

Participant Details

3

Coupon Code

4

Terms & Condition

Read the full Terms & Conditions

Conference Session Tracks

UN SDG Wheel

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

SDG 3 SDG 4 SDG 9 SDG 10
01 Advancements in Biologic Therapies for Rheumatic Diseases +
This track will explore the latest developments in biologic therapies targeting various rheumatic conditions. Emphasis will be placed on clinical efficacy, safety profiles, and long-term outcomes.
SDG 3 SDG 4
02 Molecular Diagnostics in Rheumatology +
Participants will discuss innovative molecular diagnostic techniques that enhance the understanding and management of rheumatic diseases. The focus will be on how these advancements can improve patient stratification and treatment personalization.
SDG 3 SDG 9
03 Translational Research in Rheumatology +
This session will highlight the bridge between laboratory research and clinical application in rheumatology. Presentations will cover novel findings that have the potential to transform therapeutic approaches.
SDG 3 SDG 9
04 Immunological Mechanisms in Rheumatic Diseases +
The track will delve into the immunological underpinnings of rheumatic diseases, focusing on the role of immune cells and cytokines. Discussions will aim to elucidate potential therapeutic targets for intervention.
SDG 3 SDG 4
05 Patient Care Strategies in Rheumatology +
This session will address best practices in patient care for individuals with rheumatic conditions. Emphasis will be placed on multidisciplinary approaches and patient-centered care models.
SDG 3 SDG 10
06 Innovations in Laboratory Techniques for Rheumatology +
Participants will examine cutting-edge laboratory techniques that enhance the diagnosis and monitoring of rheumatic diseases. The focus will be on high-throughput technologies and their clinical applications.
SDG 3 SDG 9
07 Therapeutic Strategies in Managing Chronic Inflammation +
This track will explore various therapeutic strategies aimed at managing chronic inflammation in rheumatic diseases. Discussions will include pharmacological and non-pharmacological interventions.
SDG 3 SDG 4
08 Biomarker Discovery and Validation in Rheumatology +
This session will focus on the identification and validation of biomarkers that can predict disease progression and treatment response in rheumatic patients. The implications for personalized medicine will be a key theme.
SDG 3 SDG 9
09 Clinical Research Methodologies in Rheumatology +
Participants will discuss innovative methodologies in clinical research specific to rheumatology. Emphasis will be placed on study design, data analysis, and ethical considerations.
SDG 3 SDG 9
10 Challenges in the Implementation of Biologic Therapies +
This track will address the barriers to the effective implementation of biologic therapies in clinical practice. Discussions will include access issues, cost-effectiveness, and patient adherence.
SDG 3 SDG 10
11 Future Directions in Rheumatology Research +
This session will explore emerging trends and future directions in rheumatology research. Participants will discuss the potential impact of novel therapies and technologies on patient outcomes.
SDG 3 SDG 9